Automated contrast medium monitoring system for computed tomography – Intra-institutional audit

Iodinated contrast media (CM) are the most widely consumed drugs by hospitals in imaging procedures around the world. As other pharmaceutical products, iodinated CM are not completely devoid of risk and may therefore be associated with adverse reactions, which can be classified as non-renal and renal [1]. Non-renal adverse reactions (incidence 0.5–1% [2–4]) are CM dose-independent and can be classified as acute (occurring within 1h of CM administration), late (occurring 1h to 1 week after CM administration) and very late (occurring more than 1 week after CM administration) [1].
Source: Computerized Medical Imaging and Graphics - Category: Radiology Authors: Source Type: research